The executive leadership team at Krystal Biotech comprises seasoned professionals with extensive experience across biotechnology operations, clinical research, financial management, and global commercialization. Krish S. Krishnan leads the corporation as the Chairman and Chief Executive Officer, steering overall corporate strategy and long-term vision. Suma Krishnan serves as the President of Research and Development, overseeing the scientific progression and pipeline expansion of the company's proprietary gene therapy platform. The executive roster also includes other key operational leaders managing financial performance, legal compliance, global regulatory affairs, and commercial manufacturing. This leadership team works cohesively to ensure strict adherence to regulatory standards while aggressively scaling the company's worldwide commercial infrastructure and advancing its clinical pipeline.